Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma

NCT01711177 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Primary Open Angle Glaucoma

Interventions

DRUG: placebo
DRUG: travoprost

Sponsor

Université de Montréal